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Abstract
 
We describe the anatomical localization of three distinct dendritic cell (DC) subsets in the mu-
rine Peyer’s patch (PP) and explore the role of chemokines in their recruitment. By two-color
 
in situ immunofluorescence, CD11b
 
1
 
 myeloid DCs were determined to be present in the sub-
epithelial dome (SED) region, whereas CD8
 
a
 
1
 
 lymphoid DCs are present in the T cell–rich
interfollicular region (IFR). DCs that lack expression of CD8
 
a
 
 or CD11b (double negative)
are present in both the SED and IFR. By in situ hybridization, macrophage inflammatory pro-
tein (MIP)-3
 
a
 
 mRNA was dramatically expressed only by the follicle-associated epithelium
overlying the SED, while its receptor, CCR6, was concentrated in the SED. In contrast,
CCR7 was expressed predominantly in the IFR. Consistent with these findings, reverse tran-
scriptase polymerase chain reaction analysis and in vitro chemotaxis assays using freshly isolated
DCs revealed that CCR6 was functionally expressed only by DC subsets present in the SED,
while all subsets expressed functional CCR7. Moreover, none of the splenic DC subsets mi-
grated toward MIP-3
 
a
 
. These data support a distinct role for MIP-3
 
a
 
/CCR6 in recruitment
of CD11b
 
1
 
 DCs toward the mucosal surfaces and for MIP-3
 
b
 
/CCR7 in attraction of CD8
 
a
 
1
 
DCs to the T cell regions. Finally, we demonstrated that all DC subsets expressed an immature
phenotype when freshly isolated and maintained expression of subset markers upon maturation
in vitro. In contrast, CCR7 expression by myeloid PP DCs was enhanced with maturation in
vitro. In addition, this subset disappeared from the SED and appeared in the IFR after micro-
bial stimulation in vivo, suggesting that immature myeloid SED DCs capture antigens and mi-
grate to IFR to initiate T cell responses after mucosal microbial infections.
Key words: chemokine • migration • T cell region • mucosal immunity • follicle-associated 
epithelium
 
Introduction
 
The precise role of dendritic cell (DC)
 
1
 
 populations in reg-
ulating the immune responses to orally administered anti-
gens remains unclear. We have focused our studies on DCs
in the Peyer’s patch (PP), as this lymphoid tissue is the pri-
mary site for the induction of mucosal immune responses,
such as the differentiation of B cells capable of producing
secretory IgA. It is also likely the initial site for the genera-
tion of regulatory T cells producing IL-10 and TGF-
 
b
 
 after
low dose antigen feeding. In addition, prior studies sug-
gested that PP DCs may be unique in their ability to prime
T cells for providing help for IgA B cell differentiation (1).
 
In previous studies, we identified two distinct subsets of
DCs in murine PP by immunohistochemical analysis (2).
One population of DCs resides in the subepithelial dome
(SED) region and is positioned to capture antigens trans-
ported by overlying M cells, whereas the other subset re-
sides in the T cell–rich interfollicular region (IFR), where
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 DC, dendritic cell; DN, double-nega-
tive; FAE, follicle-associated epithelium; HRP, horseradish peroxidase;
IFR, interfollicular region; ISH, in situ hybridization; MIP, macrophage
inflammatory protein; PP, Peyer’s patch; SED, subepithelial dome; SLC,
secondary lymphoid organ chemokine. 
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naive T cells are likely activated to become effector cells.
Based on surface marker expression, we suggested that
SED DCs may be less mature than IFR region DCs and
speculated that antigens may be captured by cells in the
SED and migrate to the IFR to prime T cells. More re-
cently, we demonstrated that freshly isolated total PP DCs
have distinct functions compared with splenic DCs with
regard to their capacity to induce T helper cell differentia-
tion in vitro (3). PP DCs were shown to prime naive
CD4
 
1
 
 antigen-specific T cells to secrete IL-10, IL-4, and
IFN-
 
g
 
, whereas spleen DCs primed for secretion of pre-
dominantly IFN-
 
g
 
. In addition, only PP DCs were shown
to produce significant levels of IL-10 after stimulation in
vitro with recombinant CD40 ligand. These data suggest
that PP DCs have a particular capacity to induce the differ-
entiation of T cells that produce IL-4 and IL-10 as well
as TGF-
 
b
 
, cytokines that are important for IgA B cell dif-
ferentiation and bystander suppression after oral antigen
feeding.
It is now clear that there are at least two subclasses of
DCs that are distinct in their phenotype and function and
that may arise from distinct hematopoietic cell lineages. In
the mouse, DCs derived from lymphoid precursors (lym-
phoid DCs) express the CD8
 
aa
 
 homodimer, whereas
those derived from myeloid precursors (myeloid DCs) ex-
press the CD11b molecule. Originally, lymphoid DCs
were identified by Ardavin et al. as thymic DCs that share a
close developmental pathway with T cell precursors (4). It
has been argued that these DCs may be tolerogenic due to
their limited capacity to induce T cell proliferation and
their enhanced ability to induce Fas-mediated apoptosis of
CD4
 
1
 
 T cells (5). In contrast, murine myeloid DCs induce
vigorous proliferative responses of CD4
 
1
 
 T cells in vitro.
Recently, two independent groups have reported that
these two DC subsets may also have a differential capacity
to induce T cell differentiation. Thus, it was shown that
foot pad injection of splenic lymphoid (CD8
 
a
 
1
 
) or my-
eloid (CD8
 
a
 
2
 
) DCs, pulsed with antigen ex vivo, induced
T cell responses skewed toward Th1 and Th2, respectively
(6, 7).
In prior studies, we characterized the expression of lin-
eage-specific markers by DCs freshly isolated from the PP
and spleen and found that myeloid (CD11b) and lymphoid
(CD8
 
a
 
) markers were similarly expressed by DCs from the
two lymphoid sites (3). We have now obtained data dem-
onstrating that the particular ability of isolated total PP DC
populations to produce IL-10 and skew T cell responses to
Th2 differentiation, as discussed above, can be attributed to
the CD11b
 
1
 
/CD8
 
a
 
2
 
 PP DC subset (Iwasaki, A., and B.L.
Kelsall, manuscript in preparation). Thus, in addition to the
differing capacities of lymphoid and myeloid DCs to in-
duce distinct pathways of T cell differentiation, these data
suggest that myeloid DCs from distinct tissues may also dif-
fer in this capacity.
We undertook the current study to gain a better under-
standing of the role of lymphoid and myeloid DCs in the
complex environment of the PP. We initially determined
the location of lymphoid and myeloid DC subsets in the
 
PP by performing two-color immunofluorescence micros-
copy with antibodies against CD11c (which is expressed on
both DC subsets) and lineage-related antigens CD8
 
a
 
,
DEC-205, and CD11b. We found that myeloid DCs are
located predominantly, if not exclusively, in the SED of
the PP, whereas lymphoid DCs are located in the IFR. In
addition, we identified a population of DCs at both sites
that expresses neither CD11b nor CD8
 
a
 
.
We next explored the role of chemokines in the local-
ization of these DC subsets to different regions of the PP.
Chemokines are a superfamily of molecules originally de-
scribed as proinflammatory chemotactic cytokines capable
of inducing transendothelial migration of leukocytes into
inflammatory sites. More recently, the functional scope of
the chemokine family has been broadened by studies sug-
gesting that chemokines also affect the normal trafficking of
cells into distinct regions of uninflamed lymphoid organs
(8). Little is known, however, about the role of specific
chemokines in the migration and localization of DCs in
vivo, primarily because most studies to date have only ex-
amined the responsiveness of in vitro–derived DCs to vari-
ous chemokines. In the studies presented here, we focused
on two chemokine/receptor pairs that have been suggested
to play a role in DC trafficking to mucosal surfaces and
lymphoid organs, namely, macrophage inflammatory pro-
tein (MIP)-3
 
a
 
/CCR6 and MIP-3
 
b
 
 and secondary lym-
phoid organ chemokine (SLC)/CCR7, respectively (9).
We now present data demonstrating that mRNA for
MIP-3
 
a
 
 is dramatically expressed in follicle-associated epi-
thelium (FAE). In addition, we show that myeloid SED
DCs, but not lymphoid IFR DCs, express mRNA for
CCR6 and migrate toward MIP-3
 
a
 
. In contrast, there is
negligible expression of MIP-3
 
a
 
 in the spleen, and unlike
the PP myeloid DCs, splenic myeloid DCs do not migrate
toward MIP-3
 
a
 
 despite their expression of the receptor for
MIP-3
 
a
 
, CCR6. Finally, we addressed the effect of matu-
ration on DC subset stability and chemokine responsive-
ness. We determined that all DC subsets expressed a simi-
larly immature phenotype when freshly isolated and
maintained expression of subset markers upon maturation
in vitro. In contrast, the expression of CCR7 was en-
hanced with maturation in vitro, and this correlated with
the ability of PP myeloid DCs to migrate from the SED to
the IFR after microbial stimulation in vivo. These are the
first data to demonstrate the localization and chemotactic
properties of DC subsets in the murine PP and to show
that a physiologically relevant DC population is attracted to
MIP-3
 
a
 
 expressed by noninflamed mucosal tissue.
 
Materials and Methods
 
Animals.
 
6–8-wk-old female BALB/c mice were obtained
from the National Cancer Institute (Frederick, MD).
 
Antibodies.
 
Identification of DC subsets was carried out using
purified anti-CD11c (N418), anti-CD11b (M1/70), anti-CD8
 
a
 
(53-6.7), and anti-DEC-205 (NLDC-145). The above antibod-
ies were purified from hybridoma supernatant grown in serum-
free hybridoma media (Life Technologies) in the CELLMAX
 
® 
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artificial capillary system (Spectrum), except for 53-6.7, which
was purchased from PharMingen. Flow cytometric sorting of
DC subsets was carried out using either FITC- or PE-conjugated
anti-CD11c (HL3), anti-CD11b (M1/70), anti-CD8
 
a
 
 (53-6.7),
and anti-CD45R (RA3-6B2). Before staining, Fc receptors
(Fc
 
g
 
RIII/II) were blocked using anti–mouse CD16/CD32
(2.4G2). The above antibodies were purchased from PharMin-
gen. Isotype-matched controls used for staining DCs included rat
IgG2a, 
 
k
 
 (R35-95), rat IgG2b, 
 
k
 
 (R35-38 or A95-1), and ham-
ster IgG (G235-2356), which were all purchased from Phar-
Mingen.
 
Double Immunofluorescence Staining of PPs.
 
PPs were dissected
from small intestines of either naive BALB/c mice or those in-
jected intravenously with 25 
 
m
 
g of STAg (soluble 
 
Toxoplasma
gondii
 
 tachyzoite antigen; provided by Dr. A. Sher, NIH, Be-
thesda, MD) 6 h earlier and were frozen in OCT medium
(Sakura Finetek, U.S.A. Inc.). 8-
 
m
 
m sections were fixed in cold
acetone and stained for DC markers using TSA
 
®
 
-Direct kit ac-
cording to the manufacturer’s instructions (NEN Life Science
Products, Inc.). In brief, endogenous peroxidase activity was
quenched with 3% H
 
2
 
O
 
2
 
 for 10 min. Sections were blocked
with TNB buffer (NEN Life Science Products, Inc.), and 2 
 
m
 
g/
ml (anti-CD11c) or 10 
 
m
 
g/ml (anti-CD11b, anti-CD8, and anti-
DEC-205) of purified primary antibodies was applied for 1 h at
room temperature. Slides were washed and incubated with
horseradish peroxidase (HRP)-conjugated mouse F(ab
 
9
 
)
 
2
 
 anti–rat
IgG (Jackson ImmunoResearch Labs., Inc.) for 30 min. DC lin-
eage marker antibodies of the rat IgG isotype (CD11b, CD8
 
a
 
,
and DEC-205) were detected with Cy3–Tyramide. Next, pri-
mary HRP was deactivated by treatment with 3% H
 
2
 
O
 
2
 
 for 10
min, and the sections were then incubated with biotinylated goat
anti–hamster IgG (Vector Labs., Inc.). Slides were washed and
incubated with streptavidin–HRP (NEN Life Science Products,
Inc.). Staining by hamster anti-CD11c was visualized by amplifi-
cation of the signal with FITC–Tyramide. Slides were mounted
with Vectashield (Vector Labs., Inc.) and were analyzed by con-
focal microscopy with Zeiss Axioplan/BioRad MRC 1024 con-
focal laser microscope using a 40
 
3 
 
objective with oil.
 
In Situ Hybridization.
 
In situ hybridization (ISH) was per-
formed as previously described (10) by Molecular Histology, Inc.
In brief, MIP-3
 
a
 
 was amplified by PCR using forward (5
 
9
 
-
CCGGAATTCTACATCAACTCCTGGAGCTG-3
 
9
 
) and re-
verse (5
 
9
 
-GCGGTGGCGGCCGCCTGTGTCCAATTCCAT-
CCCA-3
 
9
 
) primers using Taq DNA polymerase (Takara). The
PCR product containing EcoRI and NotI sites was inserted into
pBluescript SKII (Stratagene, Inc.) at these sites. The CCR6 se-
quence was amplified from cDNA using the forward and reverse
primers, 5
 
9
 
-GAATGAATTCCACAGAG-3
 
9
 
 and 5
 
9
 
-CAATGT-
TGCTTTGTGCTC-3
 
9
 
, respectively, and was inserted into
PCR2.1-TOPO vector (Invitrogen Corp.). Both orientations
were selected and linearized using HindIII for generation of
sense and antisense probes. The CCR7 sequence was prepared
by PCR amplification of cDNA from total mouse splenocytes
using primer pairs (forward, 5
 
9
 
-CGCGCGGGATCCATGGAC-
CAGGGGAAACCC-3
 
9 
 
and reverse, 5
 
9
 
-GCGCGCTCTAGAC-
TACGGGGAGAAGGTTGT-3
 
9
 
) containing restriction enzyme
sites BamHI and XbaI for inserting into the pGEM-11Zf(
 
1
 
)
vector (Promega Corp.). The 
 
35
 
S-labeled sense and antisense ri-
boprobes for MIP-3
 
a
 
, CCR6, and CCR7 were synthesized
from these constructs containing full coding region sequences us-
ing T7, T3, or SP6 RNA polymerases. For ISH, paraffin-embed-
ded sections of mouse spleen and PP were deparaffinized and
pretreated with proteinase K at 37
 
8
 
C for 15 min. Nonspecific
 
binding of probe was reduced by succinylation (1% succinic an-
hydride) and acetylation in 0.1 M triethanolamine. The slides
were hybridized with a labeled probe at 1.6 
 
3 
 
10
 
5
 
 cpm/ml incu-
bated at 45
 
8
 
C overnight. The sections were washed and digested
with RNase at 37
 
8
 
C for 40 min. Finally, slides were washed with
2
 
3
 
 SCC at 60
 
8
 
C for 15 min and dehydrated with 0.3 M ammo-
nium acetate in 70% ethanol for 5 min, followed by 0.3 M am-
monium acetate in 95% ethanol for 5 min. The radioactive RNA
probe bound to tissue section was detected by emulsion autoradi-
ography using NTB-3 emulsion (Eastman Kodak Co.) and ex-
posed at 4
 
8
 
C in the dark for 3–10 d.
 
Preparation of DCs.
 
DCs were prepared from PPs and spleens
of naive 6–10-wk-old mice as previously described (3). In brief,
PPs were treated with media containing dithiothreitol and
EDTA for 90 min at 37
 
8
 
C to remove epithelial cells and were
washed extensively with HBSS. PPs and spleens were digested
with collagenase D and DNase and incubated in the presence of
5 mM EDTA at 37
 
8
 
C for 5 min. Single-cell suspension was pre-
pared, and cells were incubated with anti–mouse CD11c-coated
magnetic beads (Miltenyi Biotech) and selected on MACS™
separation columns. Cells selected on the basis of CD11c expres-
sion were then stained with PE-labeled DC lineage marker
(CD11b or CD8
 
a
 
) antibody and FITC-conjugated anti-B220
antibody. Lineage marker–positive and –negative DCs (B220
 
2
 
)
were isolated by flow cytometric sorting performed on a FAC-
Star™ sorter (Becton Dickinson). Sorted DCs were routinely
98–100% positive for CD11c. The sorted populations were rig-
orously screened for contamination by B and T lymphocytes by
performing reverse transcriptase (RT)-PCR on RNA derived
from sorted DCs as described previously (3). None of the sorted
DC populations contained macrophage contamination, as
CD11c
 
2
 
/lo
 
 macrophages are excluded by sorting cells, which ex-
pressed only high levels of CD11c (11), and F4/80 staining was
not observed on sorted DC populations. In some experiments,
these purified DC subsets were stimulated overnight in vitro
with CD40L trimer (10 
 
m
 
g/ml) provided by Immunex Corp.
 
Competitive RT-PCR for Chemokine Receptor Expression by DCs.
 
Total RNA was isolated from sorted DC populations by RNA
isolation column (QIAGEN) and subsequently digested with
RNase-free DNase (Life Technologies) to remove contaminating
genomic DNA. Single-stranded cDNA was synthesized using Su-
perScript preamplification system (Life Technologies), and PCR
was carried out for 35 cycles using primer pairs for CCR6 (forward,
5
 
9
 
-CCATGACTGACGTCTACCTGTTGAACA-3
 
9
 
; reverse,
5
 
9
 
-GAACAGCTCCAGTCCCATACCCAGCAG-3
 
9
 
), CCR7
(forward, 5
 
9
 
-GCTCAACCTGGCCGTGGCAGACATCC-3
 
9
 
; re-
verse, 5
 
9
 
-CCACTTGGATGGTGATCAAGGCCTCC-3
 
9
 
), and
 
b
 
2-microglobulin (
 
b
 
2m) (forward, 5
 
9
 
-TGACCGGCTTGTAT-
GCTATC-3
 
9
 
; reverse, 5
 
9
 
-CAGTGTGAGCCAGGATATAG-3
 
9
 
).
Oligonucleotides were synthesized by Operon Technologies. Com-
petitive RT-PCR was carried out as previously described (reference
11a). In brief, unknown amounts of cDNA from sorted DCs were
added to each PCR reaction tube. Serial dilutions (total of 10
 
3
 
four-fold dilutions) of known amounts of competitive plasmid
pMCQ (provided by Dr. D. Shire, Sanofi Recherche, Montpellier,
France) were added to the reaction tubes containing target cDNA.
The competitive plasmid DNA contained the same primer tem-
plates for 
 
b
 
2m as the target cDNA and served as internal standard.
PCR was carried out for 35 cycles as described above, and the prod-
ucts were analyzed on 1% agarose gels. The amounts of cDNA that
would generate equal band intensity to 1.5 pg of the competitive
plasmid DNA were determined for each sorted DC population and
were used for the amplification of chemokine receptor cDNA. 
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DC Chemotaxis Assay.
 
Chemotactic ability of FACS
 
®-sorted
DC subsets was analyzed using ChemoTx system according to
the manufacturer’s instructions (96-well ChemoTx chamber;
Neuro Probe, Inc.). In brief, sorted DCs were resuspended in
RPMI 1640 supplemented with 1% FCS and 25 mM Hepes.
Chemokines at 1.2 mg/ml were placed in the lower chamber,
and a filter with 5-mm pore size was placed on top. Aliquots of
20,000 cells/well were applied to the filter’s top surface, and the
plate was incubated at 378C in 5% CO2 for 4 h. The cells migrat-
ing to the bottom chamber were counted with an inverted mi-
croscope in five or more nonoverlapping fields (magnification
40). Each assay was performed in duplicate, and the results were
expressed as the mean 6 SED of migrating cells per fields
counted.
Statistical Analysis. Normally distributed continuous variable
comparisons were done using Student’s t test.
Figure 1. Localization of myeloid
and lymphoid DCs in the PP. Frozen
sections of PPs were doubly stained
with antibodies against CD11c
(green) in combination with (A) anti-
CD11b (red) or (B) anti-CD8a (red).
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Results
Localization of Myeloid and Lymphoid DCs within the Mu-
rine PP. To localize lymphoid and myeloid DCs in the
PP, frozen sections were stained with a pan-DC marker,
anti-CD11c (green), in combination with lineage-specific
markers anti-CD8a and anti-CD11b (red). As shown in
Fig. 1 A, CD11b1/CD11c1 (yellow) myeloid DCs are
clearly present within the SED region but are absent from
the IFR. CD11b1/CD11c2 (red) macrophages, however,
are prominent in the lamina propria of the villi but are not
found in the SED or the follicles and are found only occa-
sionally in the T cell regions of PP. In contrast to myeloid
DCs, the CD8a1 lymphoid DCs (Fig. 1 B, yellow cells)
are detected exclusively in the IFR and not in the SED or
follicle. We did find CD8a1 intraepithelial lymphocytes
(red) within the FAE (Fig. 1 B). Moreover, we identified a
novel subset of CD11c1 DCs that do not stain for either
CD11b or CD8a (Fig. 1 and data not shown). These cells
are located in both the SED and IFR (Fig. 1, green cells)
and are also negative for the DEC-205 marker. To identify
at a single-cell level the expression of lineage specific mark-
ers in situ, we carried out confocal analysis (Fig. 2). As
noted above, CD11b1 DCs were found only in the SED
region (Fig. 2 A) but not in the IFR (Fig. 2 D). In contrast,
CD8a1 and DEC-2051 DCs were present in the IFR (Fig.
2, E and F) but not in the SED region (Fig. 2, B and C). As
reported previously (12), DEC-205 was also expressed by
the epithelial cells of the intestine (Fig. 2 C). Thus, myeloid
and lymphoid DCs of the PPs localize in distinct regions,
namely, the SED and IFR, respectively.
Detection of MIP-3a, CCR6, and CCR7 mRNA Expres-
sion in the PP by ISH. We next examined the role of
chemokines in the recruitment of myeloid and lymphoid
DCs to their respective locations within the PP in vivo.
We analyzed by ISH the expression of mRNA for
chemokine receptors CCR6 and CCR7, as well as for the
CCR6 ligand MIP-3a. We focused on these chemokine/
receptor pairs, as prior studies have suggested that these
may be important for the localization of DCs within mu-
Figure 2. Confocal microscopic analysis of myeloid and lymphoid DCs in the PP. Cryostat sections of mouse PPs were doubly labeled with antibodies
against CD11c (green) in combination with (A and D) anti-CD11b (red); (B and E) anti-CD8a (red); or (C and F) anti–DEC-205. SED regions (A–C)
and IFRs (D–F) were analyzed by confocal microscopy.1386 Chemokine Recruitment of Peyer’s Patch Dendritic Cells
cosal (CCR6/MIP-3a) and lymphoid (CCR7/MIP-3b)
tissues (9). As shown in Fig. 3 C, MIP-3a mRNA was re-
markably expressed in the FAE but not within any other
regions of the PP or adjacent villi, including the villus-asso-
ciated columnar epithelium. Correspondingly, mRNA for
the MIP-3a receptor, CCR6, was strongly detected under
the FAE within the SED and was detected at lower levels
throughout the follicle (Fig. 3 A). CCR6 expression was
not found in the T cell–rich IFR or the germinal center of
the PP. In contrast, no appreciable level of expression of
MIP-3a was detected in the spleen (Iwasaki, A., and B.L.
Kelsall, unpublished observation).
In contrast to CCR6, CCR7 mRNA was found only
within the IFR of the PP (Fig. 3 B). This localization of
CCR7 mRNA overlaps with the previously reported ex-
pression pattern of its ligands MIP-3b and SLC (9, 13–16).
Moreover, we detected a sparse signal for the CCR7
within the SED region, which correlates with the distribu-
tion of myeloid DCs (Fig. 1 A). Thus, these results indicate
that in the PP, cells present in the SED region express
CCR6 and localize just under the FAE, where MIP-3a is
dominantly expressed. In contrast, cells expressing high
levels of CCR7 were found predominantly within the IFR
of the PP, where its ligands MIP-3b and SLC are also
found.
Expression of CCR6 and CCR7 by PP and Spleen DC
Subsets. To assess whether the distinct distribution pat-
tern of DC subsets in the PP may be attributed to differen-
tial chemokine receptor expression and recruitment, we
first examined the expression of chemokine receptor
mRNA by RT-PCR. Concurrently, we examined the ex-
pression of CCR6 and CCR7 by the splenic DC counter-
parts of the three distinct DC subsets found in the PP.
Thus, CD11c1 DCs from PPs and spleens were freshly iso-
lated by a previously published magnetic selection method
(3). The DCs were further FACS® sorted to 98–100%
purity into the three subsets described above, namely,
CD11b1/CD8a2/CD11c1 (myeloid), CD11b2/CD8a1/
CD11c1 (lymphoid), or double-negative (DN) CD11b2/
CD8a2/CD11c1 DCs. Contamination by B cells, T cells,
epithelial cells, and macrophages of purified DCs was ex-
cluded by rigorous screening with flow cytometry and
RT-PCR (reference 3; data not shown). These purified
DC subsets were assessed for the expression of mRNA for
CCR6 and CCR7 by RT-PCR. The amounts of template
cDNA used for each PCR were equalized by first per-
forming competitive PCR using primers specific for b2m
(Fig. 4). As depicted in Fig. 4 A, CD11b1 myeloid DCs
from PP were found to express CCR6, whereas CD8a1
PP DCs did not. A moderate level of mRNA for CCR6
was also detected from DN (CD11b2/CD8a2) DCs. In
contrast, CCR7 was expressed at similar levels by both
myeloid and lymphoid DCs from the PP and to a lesser ex-
tent by DN DCs. In the spleen, mRNA for CCR6 was
detected only in myeloid and to a lesser extent in DN
DCs, but not in lymphoid DCs; CCR7 mRNA was de-
tected in all subsets (Fig. 4 B). The level of mRNA for
CCR7 was found to be consistently higher in the myeloid
splenic DCs compared with the other subsets.
Thus, in the PP, myeloid DCs that were determined by
immunofluorescence staining to be located in the SED ex-
press both CCR6 and CCR7, whereas lymphoid DCs
found in the IFR express only CCR7. In the spleen, my-
eloid DCs, which localize in the marginal zone (reference
Figure 3. Expression of MIP-3a, CCR6, and CCR7 in the PP. Antisense and sense riboprobes were hybridized to paraffin-embedded sections of
the PP. The radioactive RNA probe bound to tissue section was detected by emulsion autoradiography. Darkfield images are shown for antisense
CCR6 (A), CCR7 (B), and MIP-3a (C) and sense CCR6 (D), CCR7 (E), and MIP-3a (F) in the PP. Black arrows indicate the SED, and white ar-
rows point toward IFR.1387 Iwasaki and Kelsall
17 and data not shown), express both CCR6 and CCR7
mRNA, whereas lymphoid DCs that localize in the periar-
teriolar lymphoid sheath (reference 17 and data not shown)
were found to express only CCR7. Taken together, the
expression of chemokine receptor mRNA by the DC sub-
sets as determined by RT-PCR and the localization of
these cell subsets by immunofluorescence correlates with
the chemokine receptor mRNA expression as determined
in ISH.
Myeloid PP DCs Migrate toward MIP-3a. In the next
set of experiments, the migratory capacity of the three pu-
rified subsets of PP and splenic DCs toward MIP-3a,
MIP-3b, and SLC was assessed by an in vitro chemotaxis
assay. As shown in Fig. 5 A, the strongest migration to-
ward MIP-3a was demonstrated by the myeloid CD11b1
PP DCs. In contrast, no statistically significant migration
toward MIP-3a by the DN or lymphoid PP DCs was ob-
served. Thus, the PP DC subset that migrated toward
MIP-3a corresponded to that solely located just under-
neath the FAE, namely, the CD11b1 myeloid DCs. How-
ever, all PP DC populations migrated toward MIP-3b and
SLC to a similar extent, consistent with the presence of
CCR7 mRNA expressed by these subsets.
In the spleen, the myeloid DCs, although expressing high
levels of CCR6 mRNA (Fig. 4 B), did not migrate toward
MIP-3a. As in the PP, all subsets of splenic DCs migrated
comparably to MIP-3b and SLC (Fig. 5 B). These data in-
dicated that the myeloid DCs located in the PP SED are
unique in their ability to migrate toward MIP-3a.
Thus, in the PP, the migratory capacity of myeloid and
lymphoid DCs correlates with their selective chemokine
receptor expression. Specifically, the CD11b1 PP DC sub-
set expresses both CCR6 and CCR7 mRNA and migrates
toward MIP-3a, MIP-3b, and SLC. In contrast, CD8a1
PP DCs express only CCR7 mRNA and migrate toward
MIP-3b and SLC but not to MIP-3a. In the spleen, al-
though the myeloid and DN DCs express CCR6 mRNA,
all subsets of DCs migrated toward MIP-3b and SLC but
not to MIP-3a.
PP Myeloid and Lymphoid DCs Maintain their Lineage
Markers and Upregulate CCR7 Expression during In Vitro
Maturation. In a final series of studies, we addressed the
effect of maturation status on DC subsets stability and
chemokine responsiveness. In our previous study, we
showed that overnight in vitro culture of total PP DCs, in-
cluding those from the SED, induces differentiation into
cells expressing the phenotype of IFR DCs, namely the
expression of the DEC-205 molecule (2). This data im-
Figure 4. Semiquantitative RT-PCR for CCR6 and CCR7 mRNA
on FACS®-sorted fresh and stimulated DC subsets from the PP and
spleen. Total RNA was isolated from FACS®-sorted CD11b1, CD8a1,
or DN PP (A) or spleen (B) freshly isolated DCs. RNA was also isolated
from either freshly isolated or in vitro–stimulated CD8a1 or CD8a2 PP
(C) or spleen (D) DCs. The cDNA was prepared, and the amount used
for each PCR was equalized by competitive PCR using primers for the
control gene (b2m) (bottom panels). The levels of CCR6 (top panels)
and CCR7 (middle panels) mRNA expression were determined using
specific primers as described in Materials and Methods. The amplification
fragments were visualized on 1% agarose gel using ethidium bromide.
Similar results were obtained from three independent experiments.
Figure 5. Chemotactic capacity of DC subsets toward MIP-3a and
MIP-3b. FACS®-purified myeloid (CD11b1), DN (CD11b2/CD8a2),
and lymphoid (CD8a1) DCs from PP (A) or spleen (B) were placed in
the chemotaxis chamber in duplicates. Results are expressed as the aver-
age number of cells migrating to the bottom chamber per field. At least
five independent fields were counted per bottom chamber. The P values
for DC migration to MIP-3a compared with the media control are indi-
cated. The data is representative of five independent experiments.1388 Chemokine Recruitment of Peyer’s Patch Dendritic Cells
plied that either SED DCs convert to IFR DC upon mat-
uration or that DEC-205 expression is upregulated during
maturation on both subsets of DCs. To distinguish be-
tween these possibilities, freshly isolated FACS®-purified
CD8a2 SED DCs and CD8a1 IFR DCs were stimulated
overnight in vitro in the presence of recombinant murine
CD40 ligand trimer and were assessed for their surface ex-
pression of lineage and activation markers. As depicted in
Fig. 6, both CD8a1 and CD8a2 DCs upregulated the ex-
pression of CD80, CD86, and MHC class II molecules to a
similar degree. Moreover, although the expression of
DEC-205 molecules on freshly isolated CD8a1 DCs was
higher compared with CD8a2 DCs, both of these DC
subsets increased the expression of DEC-205 during the
overnight culture. Thus, DEC-205 represents a maturation
marker and is not restricted to the lymphoid lineage. Inter-
estingly, the expression of CD8a and CD11b lineage
markers by the two subsets was maintained upon matura-
tion. Thus, the CD8a2 DC subset did not downmodulate
CD11b expression and become CD8a1 DCs, nor did
CD8a1 DCs become CD11b1 during the maturation pro-
cess. These data suggest that the SED myeloid DCs do not
simply represent the immature stage of the IFR lymphoid
DCs. Moreover, DN PP DCs were never found to express
either CD8a or CD11b upon maturation in vitro (data not
shown). Thus, the three subsets of DCs appear to belong
to distinct classes that do not readily converge upon matu-
ration.
Next, we examined the regulation of chemokine recep-
tor expression by myeloid and lymphoid DC subsets dur-
ing overnight in vitro stimulation. The level of mRNA
expression for CCR6 and CCR7 was determined by semi-
quantitative RT-PCR as described above from either
freshly isolated or in vitro–stimulated FACS®-sorted DC
populations. As shown in Fig. 4 D, CCR6 expression by
the CD8a2 DCs from spleen was diminished during the in
Figure 6. Flow cytometric analysis of
CD8a1 and CD8a2 PP DCs upon
stimulation in vitro. Highly purified
CD8a1 and CD8a2 DCs from PP were
isolated using flow cytometric sorting,
and surface expression markers on freshly
isolated (left) and in vitro–activated
(right) DCs were determined by flow
cytometry. The same concentrations of
antibodies were used to stain the DCs at
left and right. This figure is a representa-
tive of three similar experiments.1389 Iwasaki and Kelsall
vitro stimulation. The CCR6 mRNA level of PP CD8a2
DCs was minimally altered upon maturation (Fig. 4 C).
On the other hand, CCR7 expression was enhanced by
both splenic and PP CD8a2 DCs. The lymphoid CD8a1
DCs in both organs also enhanced the level of CCR7
upon maturation in vitro.
Myeloid PP DCs Migrate toward the T Cell Region upon
Microbial Stimulation In Vivo. Finally, to examine the mi-
gration of DC subsets in the PP after microbial stimulation
in vivo, BALB/c mice were given a systemic injection of
STAg. In previous studies, STAg has been shown to in-
duce rapid migration of splenic DCs to the inner T cell re-
gions after systemic injection (18). When PPs from mice
injected with STAg 6 h earlier were examined, there was a
complete loss of CD11b1 DCs from the SED region (Fig.
7 A). This remarkable depletion of SED myeloid DCs was
accompanied by the appearance of CD11b1 DCs in the
IFR (Fig. 7 B). The CD8a1 DC population was expanded
by the STAg injection but was still localized within the
IFR (data not shown). Thus, in vivo, myeloid DCs appear
to migrate from SED toward the T cell region of the PP
upon microbial stimulation.
Discussion
In this report, we describe the location of DC subsets in
the murine PP. We show that in an unperturbed state,
myeloid (CD11b1/CD8a2) and lymphoid (CD11b2/
CD8a1) DCs are distributed to distinct regions, namely
the SED and IFR, respectively. In addition, we demon-
strate the presence of a significant novel population of
CD11b2/CD8a2 DCs at both sites. Next, we show that
myeloid PP DCs express CCR6 and migrate toward MIP-
3a, which is expressed predominantly by the FAE. This
ability of myeloid DCs to migrate toward MIP-3a is
unique to the PP, as the splenic myeloid DCs do not
migrate toward this chemokine, although they express
mRNA for CCR6. In contrast, lymphoid DCs from PP
and spleen express only CCR7 and migrate toward MIP-
3b and SLC but not to MIP-3a. Finally, in a last series of
experiments, we addressed the effect of maturation status
on DC subset stability and chemokine responsiveness.
When freshly isolated, all DC subsets expressed a similarly
immature phenotype. Upon differentiation in vitro, for all
DC subsets, the levels of expression of CD8a and CD11b
were unaltered, thus demonstrating the stability of these
Figure 7. In vivo migration of myeloid DCs from the
SED to the IFR of the PP upon microbial stimulation.
Cryostat sections of PPs were obtained from mice in-
jected systemically with STAg 6 h earlier and were dou-
bly labeled with antibodies against CD11c (green) in
combination with anti-CD11b (red). The SED region
(A) and IFR (B) were analyzed by confocal microscopy.
The experiment was repeated twice with similar data.1390 Chemokine Recruitment of Peyer’s Patch Dendritic Cells
DC subsets. In contrast, expression of CCR7 was enhanced
with maturation in vitro, and this correlated with the abil-
ity of PP myeloid DCs to migrate from the SED to the
IFR after microbial stimulation in vivo.
The DC system is continuously being defined, and in
both humans and mice, subsets of DCs with distinct phe-
notypes and functions have been described. However, as
most studies to date have focused on DCs derived in vitro
from cell precursors, the precise role of distinct DC subsets
in vivo is not clear. In addition, there are significant differ-
ences between the functional phenotypes of DCs in mice
and humans. In mice, two independent studies have dem-
onstrated that subcutaneous injection of lymphoid DCs
from the spleen pulsed with antigen induces Th1 responses,
whereas splenic myeloid DCs induce Th2 responses in
draining lymph nodes (6, 7). In humans, however, the data
concerning lymphoid and myeloid DC subsets is much less
clear. Human plasmacytoid cells (lymphoid DCs) were
originally shown to differentiate allogeneic T cells to se-
crete Th2 cytokines, whereas myeloid DCs were shown to
induce Th1 cytokine secretion (19). In contrast, a recent
report by Cella et al. showed that there is minimal differ-
ence in the capacity of myeloid versus lymphoid DCs to
differentiate naive Th cells toward either Th1 or Th2 (20).
Clearly, more studies are needed to clarify the role of DC
subsets in vivo.
The distinct localization of the myeloid and lymphoid
DCs prompted us to investigate the role of chemokines in
recruitment of these cells to their respective areas within
the PP. Initially, we examined the expression pattern of the
chemokine MIP-3a within the PP by ISH. A remarkable
expression of MIP-3a was detected within the FAE, but
not within the epithelium overlying the villi. These find-
ings are somewhat inconsistent with a previous report de-
scribing the expression of MIP-3a mRNA in the non-
FAE, as well as FAE of small intestine and colon in mice
(21). This difference may be attributed to differences in the
sensitivity of the probes employed for the ISH assays. In
the spleen, no signal for MIP-3a mRNA was detected
(Iwasaki, A., and B.L. Kelsall, unpublished observation),
suggesting that MIP-3a may have a unique role in recruit-
ing cells to mucosal surfaces. The mRNA of the receptor
for MIP-3a, CCR6, was expressed in the SED as well as in
the B cell follicle and mixed T cell and B cell region bor-
dering the IFR and the follicles in the PP. CCR6 was not
found to be highly expressed in the germinal center. In ad-
dition to its expression on CD11b1 and DN DCs, CCR6
may also be found on B cells and memory T lymphocytes
in the PP, as the equivalent human cells have been shown
to express CCR6 mRNA and protein (22). Thus, to ad-
dress specifically the role of MIP-3a in DC recruitment in
vivo, three distinct DC subsets were purified from the PP
and spleen. Using semiquantitative RT-PCR analysis of
mRNA from these purified DCs, we detected CCR6
mRNA from DCs residing in the SED (CD11b1 and
CD11b2/CD8a2) but not from those present in the IFR
(CD8a1). Moreover, correlating with the receptor mRNA
expression pattern, the migratory capacity of DCs toward
MIP-3a was restricted to the SED (myeloid) DCs and was
not seen in the IFR (lymphoid) DCs. In the spleen, how-
ever, although a similar pattern of receptor mRNA expres-
sion was detected in the corresponding DC subsets, none
of the subsets migrated toward MIP-3a. It is unclear why
the splenic CD11b1 and the DN DCs of the spleen and
PP, while expressing CCR6 mRNA, do not migrate to-
ward MIP-3a. Whether posttranscriptional regulation of
the CCR6 gene product or inhibitors of downstream sig-
naling molecules are differentially regulated in the these
DCs remains to be addressed. Taken together with the lo-
calization data, our data suggest that MIP-3a secreted by
the FAE acts to recruit CD11b1 PP DCs to the SED re-
gion.
In contrast to CCR6 mRNA, the expression of CCR7
mRNA was confined mainly to the IFR of the PP (Fig. 3).
As CCR71 cells in the IFR may include CD41 and CD81
T cells as well as lymphoid DCs, we purified DC subsets to
specifically analyze their migratory capacity. Interestingly,
all DC subsets expressed CCR7 mRNA, as measured by
RT-PCR, and migrated toward MIP-3b and SLC. It re-
mains a mystery as to how CD11b1 DCs remain in the
SED despite their ability to migrate toward SLC and MIP-
3b, as assessed by our in vitro chemotaxis assay. One possi-
bility is that in the PP, CD11b1 DCs are retained in the
SED due to very high levels of MIP-3a secreted by the
FAE compared with the levels of MIP-3b or SLC secreted
by the cells in the IFR. Upon encounter with pathogens,
however, these cells acquire selective ability to migrate to-
ward the T cell region MIP-3b and SLC by upregulating
the CCR7 molecule (Fig. 4 C). Indeed, we observed the
migration of myeloid CD11b1 DCs from the SED to IFR
after STAg stimulation in vivo (Fig. 7). This observation is
supported by an earlier study of human CD341 cell–derived
DCs in which the immature DCs are shown to express
CCR6 but not CCR7 mRNA and respond only to MIP-
3a. However, upon stimulation with LPS or TNF-a, these
cells now begin to respond to MIP-3b and SLC by de
novo expression of CCR7 (9).
Although a number of studies have investigated the ex-
pression pattern and migration toward MIP-3a by diverse
cell subsets, the precise in vivo function of MIP-3a re-
mains unclear. As discussed above, in human in vitro–cul-
tured DCs, the expression of CCR6 mRNA and chemo-
taxis toward MIP-3a was found in immature CD341
progenitor-derived or transiently adherent lung DCs but
not in monocyte-derived DCs (9, 22–24). In mice, Ogata
et al. reported the lack of CCR6 mRNA in different in
vitro–cultured, bone marrow–derived DC subsets tested
(25). These data at first may seem to conflict with our result
showing that myeloid DCs in the PP express CCR6 and
migrate toward MIP-3a. However, a recent report by
Yang et al. demonstrated that human monocyte-derived
DCs can be made to express CCR6 mRNA and migrate
toward MIP-3a by in vitro culture in the presence of
TGF-b1 in addition to GM-CSF and IL-4 (26). This im-
plies that in an organ such as PP where high levels of TGF-
b1, 2, and 3 are constitutively present (Iwasaki, A., S. Ja-1391 Iwasaki and Kelsall
kowlew, and B.L. Kelsall, manuscript in preparation), my-
eloid-derived DCs may be induced to express CCR6 and
respond to MIP-3a.
Taking into consideration the results described above,
we propose the following mechanism for DC recruitment
and migration within the PP and how distinct subsets of
DCs may be involved in T cell differentiation (Fig. 8).
First, both immature myeloid and lymphoid DCs are re-
cruited to the PP by responding to MIP-3b and SLC se-
creted in the IFR. Although previous studies have sug-
gested that CCR7 expression is only detected in “mature”
DCs (9, 27), it is still possible that “immature” DCs ex-
pressing moderate levels of CCR7 are recruited to the PP.
Indeed, our data demonstrate that all freshly isolated PP
and spleen DC populations express CCR7 and migrate to-
ward SLC and MIP-3b, despite their lack of high levels of
maturation markers such as CD80 and CD86 (Fig. 6). In
addition, the level of CCR7 expression on freshly isolated
DCs is enhanced upon maturation (Fig. 4). It is also pos-
sible, and perhaps more likely, that other undefined
chemokine/receptor pairs play a role in immature DC re-
cruitment to the PP. Once within the PP, the myeloid
DCs acquire the ability to respond to MIP-3a due to the
high level of TGF-b available in this microenvironment.
They migrate to the SED region and remain there until en-
counter with antigens transported by M cells present within
the FAE. At this time, the SED DCs may lose their ability
to respond further to MIP-3a by surface receptor down-
regulation known as “desensitization” (28). If the antigen
encountered is an innocuous protein antigen (food compo-
nents), these DCs mediate the development of Th2/Th3
cells by secreting high levels of IL-10 and possibly TGF-b
(Iwasaki, A., and B.L. Kelsall, manuscript in preparation).
This process may occur in the SED (Fig. 8,  ), where
small numbers of CD41 T cells present at this site are di-
rectly activated by myeloid DCs. This may be particularly
relevant to low dose innocuous antigen feeding, where lit-
tle antigen may reach the IFR, and there may be little acti-
vation of DCs for migration to the IFR. If the antigen is a
microbial component, such as STAg, CD11b1 DCs are in-
duced to undergo maturation. This process results in the
enhanced CCR7 expression, which allows the DC to mi-
grate toward the IFR, where high levels of MIP-3b and
SLC are expressed (Fig. 8,  ). En route, myeloid or DN
DCs may differentiate into APCs capable of stimulating
Th1 responses by secreting high levels of IL-12. Indeed,
gastrointestinal pathogens known to induce strong Th1 re-
sponses at mucosal sites such as Salmonella typhimurium and
s 1
s 2
Figure 8. Proposed mechanism of DC recruitment to the distinct regions of the PP. The CD11b1 DC (CCR61/CCR71) and CD8a1 DC (CCR62/
CCR71) precursors from the blood enter the PP by responding to CCR7 ligands secreted by the IFR. The myeloid DCs acquire responsiveness to MIP-
3a due to the high levels of TGF-b present in the PPs and are thus recruited toward the FAE secreting MIP-3a. On the other hand, lymphoid DCs re-
main in the IFR due to their expression of CCR7 but not CCR6. Upon encountering luminal antigen transported via M cells, SED DCs may undergo
two distinct differentiation pathways. If the antigen encountered is an innocuous food protein, the default pathway for CD11b1 DCs is to generate Th2/
Th3 responses through secretion of high levels of IL-10 and TGF-b and low levels of IL-12 in the SED  . However, upon encounter with microbial
stimuli, such as double-stranded RNA or LPS (“danger signals”), conventional maturation of DCs is triggered  . This maturation of SED DCs leads to
their migration toward the IFR by upregulating CCR7 expression. In the IFR, naive T cells are primed to secrete IFN-g by antigen presented by the
CD11b1 DCs directly  . Alternatively, antigens processed by CD11b1 DCs may be transferred to the Th1-inducing CD8a1 DCs for subsequent pre-
sentation to naive T cells by a process known as “cross-priming”  .
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Toxoplasma gondii are capable of stimulating the secretion of
IL-12 from DCs (18, 29). The CD11b1 DCs in the IFR
stimulate T cells either directly (Fig. 8,  ) or indirectly via
transfer of antigen to CD8a1 DCs (Fig. 8,  ), a process
known as “cross-priming” (30–32). In either case, the result
is the differentiation of T cells into Th1 cytokine-secreting
phenotype. Studies to directly assess the phenotype and
function of PP DCs with respect to both chemokine recep-
tor expression and cytokine secretion after infection with
mucosal pathogens will be important to test this model.
Collectively, the data presented here suggest a role for
MIP-3a and MIP-3b and/or SLC in the recruitment of
myeloid and lymphoid DCs to the SED and IFR of PP, re-
spectively. As mRNA for MIP-3a was not detected in the
spleen but selectively expressed by mucosal epithelium, this
chemokine may be involved in the specific recruitment of
DCs to mucosal surfaces. Deciphering the mechanism by
which DCs traffic to and from mucosal lymphoid tissues
will undoubtedly be important for understanding how im-
mune responses are induced at these sites.
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